Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens

    This grant supports researchers analyzing All of Us biospecimens to study biomarkers and chronic diseases, contributing new data to advance precision medicine and broaden research resources.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Integrating Biospecimen Science Approaches into Clinical Assay Development

    NIH supports research to standardize biospecimen handling and reduce preanalytical variability for more reliable clinical cancer biomarker assays.

    HHS-NIH11Due Feb 4, 2027$1,250,000

    NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

    This grant will provide access to TOPMed resources for researchers to generate and share large-scale genetic and multi-omics data to study the molecular mechanisms of heart, lung, blood, and sleep disorders.

    HHS-NIH11Due Feb 8, 2027

    Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

    Research grant utilizing PLCO bioresources for advancing cancer etiology and early detection biomarkers through biochemical and genetic analyses.

    HHS-NIH11Due Feb 10, 2027

    Partnership with Common Fund Data Ecosystem Resources

    This grant funds projects that connect and enhance reusability between NIH Common Fund data and other biomedical data resources, supporting collaboration and data interoperability.

    HHS-NIH11Forecasted May 25, 2027$1,200,000Forecasted

    Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

    NHGRI seeks applications to study how genomic variations affect genome function and phenotypes using high-throughput methods, as part of the IGVF Consortium.

    HHS-NIH11Due Dec 14, 2026$2,000,000